Advisory Committee on Immunization Practices (ACIP), 5264-5265 [2018-02268]
Download as PDF
<![CDATA[
5264
Federal Register / Vol. 83, No. 25 / Tuesday, February 6, 2018 / Notices
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Hours per
response
Total burden
hours
ICU Assessment ..............................................................................................
ICU Action Plan ...............................................................................................
Site Visits .........................................................................................................
150
150
100
1
1
1
1.25
2
4
187.5
300
400
Total ..........................................................................................................
400
N/A
N/A
887.5
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
ICU Assessment Tool ......................................................................................
ICU Action Plan ...............................................................................................
Site Visits .........................................................................................................
150
150
100
........................
........................
........................
187.5
300
100
200
50
50
a $52.58
d 98.83
$9,858.75
15,774
2,787
6,940
2,629
4,941.50
400
887.5
N/A
42,930.25
Total ..........................................................................................................
Total burden
hours
Average
hourly wage
rate *
Form name
a 52.58
b 27.87
c 34.70
a 52.58
Total cost
burden
a Based
on the mean wages for 11–9111 Medical and Health Services Managers.
on the mean wages for 29–9099 Miscellaneous Health Practitioners and Technical Workers: Healthcare Practitioners and Technical
Workers, All Other.
c Based on the mean wages for 29–1141 Registered Nurse.
d Based on the mean wages for 29–1069 Physicians and Surgeons, All other.
National Compensation Survey: Occupational wages in the United States May 2016 ‘‘U.S. Department of Labor, Bureau of Labor Statistics:’’
https://www.bls.gov/oes/current/oes_stru.htm.
b Based
daltland on DSKBBV9HB2PROD with NOTICES
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ’s health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Karen J. Migdail,
Chief of Staff.
[FR Doc. 2018–02289 Filed 2–5–18; 8:45 am]
BILLING CODE 4160–90–P
VerDate Sep<11>2014
19:02 Feb 05, 2018
Jkt 244001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the Advisory
Committee on Immunization Practices
(ACIP). This meeting is open to the
public, limited only by room seating.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt is February 14,
2018. Written comments must include
full name, address, organizational
affiliation, email address of the speaker,
topic being addressed and specific
comments. Written comments must not
exceed one single-spaced typed page
with 1-inch margins containing all items
above. Only those written comments
SUMMARY:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
received 10 business days in advance of
the meeting will be included in the
official record of the meeting. Public
comments made in attendance must be
no longer than 3 minutes and the person
giving comments must attend the public
comment session at the start time listed
on the agenda. Time for public
comments may start before the time
indicated on the agenda. The meeting
will be webcast live via the World Wide
Web; for instructions and more
information on ACIP please visit the
ACIP website: https://www.cdc.gov/
vaccines/acip/.
DATES: The meeting will be held on
February 21, 2018, 8:00 a.m. to 5:45
p.m., EDT, and February 22, 2018, 8:00
a.m. to 12:30 p.m. EDT.
ADDRESSES: CDC, 1600 Clifton Road,
NE, Tom Harkin Global
Communications Center, Kent ‘Oz’
Nelson Auditorium, Atlanta, Georgia
30329.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, CDC, NCIRD.
Email ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
E:\FR\FM\06FEN1.SGM
06FEN1
Federal Register / Vol. 83, No. 25 / Tuesday, February 6, 2018 / Notices
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters To Be Considered: The agenda
will include discussions on Influenza
vaccines, evidence based
recommendations, anthrax vaccine,
Japanese encephalitis vaccines, hepatitis
vaccines, human papillomavirus
vaccines, pneumococcal vaccines,
meningococcal disease, and an update
on vaccines and other biologics for
prevention and treatment of healthcareassociated infections. A
recommendation vote is scheduled for
hepatitis vaccines and evidence based
recommendations. Agenda items are
subject to change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–02268 Filed 2–5–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Service
Administration
Advisory Committee on Heritable
Disorders in Newborns and Children
Health Resources and Service
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice; correction.
daltland on DSKBBV9HB2PROD with NOTICES
AGENCY:
This notice announces a
correction to the meeting announcement
for a public meeting of the Advisory
Committee on Heritable Disorders in
Newborns and Children (ACHDNC),
published in the Federal Register on
January 22, 2018. The meeting has
changed from a two-day meeting to a
SUMMARY:
VerDate Sep<11>2014
19:02 Feb 05, 2018
Jkt 244001
one-day meeting, to be held on
Thursday, February 8, 2018. Agenda
items have been updated and will
include a final evidence-based review
report on the spinal muscular atrophy
(SMA) condition nomination for
possible inclusion on the Recommended
Uniform Screening Panel (RUSP).
Following this report, the ACHDNC
expects to vote on whether to
recommend adding SMA to the RUSP to
the Secretary of HHS. The agenda will
also include presentation of a document
on cutoff determinations and risk
assessment methods used for dried
bloodspot newborn screening. The
Committee expects to vote on whether
to support this document. The ACHDNC
members will also consider a report on
Quality Measures in Newborn Screening
from the Follow up and Treatment
Workgroup. HRSA will post the agenda
two days prior to the meeting on the
Committee’s website: https://
www.hrsa.gov/advisory-committees/
heritable-disorders/. Please
note that agenda items are subject to
changes as priorities dictate.
Thursday, February 8, 2018,
from 8:30 a.m. to 3:00 p.m. ET (meeting
time is tentative).
DATES:
The address for the meeting
is 5600 Fishers Lane, 5th Floor Pavilion,
Rockville, MD 20857. Participants may
also access the meeting through
Webcast. Advanced registration is
required. Please register online at https://
www.achdncmeetings.org/ by 12:00 p.m.
ET on February 5, 2018. Instructions on
how to access the meeting via Webcast
will be provided upon registration.
Please note that the 5600 Fishers Lane
building requires security screening on
entry. Visitors must provide a driver’s
license, passport, or other form of
government-issued photo identification
or they cannot enter the facility. Per the
original meeting notice, non-US Citizens
planning to attend in person had to
provide additional information to HRSA
by January 24, 2018, 12:00 p.m. Eastern
Time.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Anyone requesting information
regarding the ACHDNC should contact
Ann Ferrero, Maternal and Child Health
Bureau (MCHB), HRSA, in one of three
ways: (1) Send a request to the following
address: Ann Ferrero, MCHB, HRSA
5600 Fishers Lane, Room 18N100C,
Rockville, MD 20857; (2) call 301–443–
3999; or (3) send an email to: AFerrero@
hrsa.gov.
Correction: Date and time of the
ACHDNC’s public meeting. The meeting
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
5265
will now be held on Thursday, February
8, 2018, from 8:30 a.m. to 3:00 p.m. ET.
Amy McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2018–02306 Filed 2–5–18; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Special Emphasis
Panel (R13) Conferences Grants.
Date: March 16, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
NIMHD, 7201 Wisconsin Ave., Suite 533,
Bethesda, MD 20814.
Contact Person: Richard C. Palmer, DRPH,
Health Scientist Administrator, National
Institute on Minority Health and Health
Disparities, National Institutes of Health,
7201 Wisconsin Ave, Bethesda, MD 20814,
(301) 451–2432, richard.palmer@nih.gov.
Dated: January 31, 2018.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–02279 Filed 2–5–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\06FEN1.SGM
06FEN1
]]>Agencies
[Federal Register Volume 83, Number 25 (Tuesday, February 6, 2018)]
[Notices]
[Pages 5264-5265]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02268]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). This meeting is open to the public, limited only by room
seating. Time will be available for public comment. The public is
welcome to submit written comments in advance of the meeting. Comments
should be submitted in writing by email to the contact person listed
below. The deadline for receipt is February 14, 2018. Written comments
must include full name, address, organizational affiliation, email
address of the speaker, topic being addressed and specific comments.
Written comments must not exceed one single-spaced typed page with 1-
inch margins containing all items above. Only those written comments
received 10 business days in advance of the meeting will be included in
the official record of the meeting. Public comments made in attendance
must be no longer than 3 minutes and the person giving comments must
attend the public comment session at the start time listed on the
agenda. Time for public comments may start before the time indicated on
the agenda. The meeting will be webcast live via the World Wide Web;
for instructions and more information on ACIP please visit the ACIP
website: https://www.cdc.gov/vaccines/acip/.
DATES: The meeting will be held on February 21, 2018, 8:00 a.m. to 5:45
p.m., EDT, and February 22, 2018, 8:00 a.m. to 12:30 p.m. EDT.
ADDRESSES: CDC, 1600 Clifton Road, NE, Tom Harkin Global Communications
Center, Kent `Oz' Nelson Auditorium, Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, CDC, NCIRD. Email [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged with advising the Director, CDC,
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s,
the committee is mandated to establish and periodically review and, as
appropriate, revise the
[[Page 5265]]
list of vaccines for administration to vaccine-eligible children
through the Vaccines for Children (VFC) program, along with schedules
regarding dosing interval, dosage, and contraindications to
administration of vaccines. Further, under provisions of the Affordable
Care Act, section 2713 of the Public Health Service Act, immunization
recommendations of the ACIP that have been approved by the Director of
the Centers for Disease Control and Prevention and appear on CDC
immunization schedules must be covered by applicable health plans.
Matters To Be Considered: The agenda will include discussions on
Influenza vaccines, evidence based recommendations, anthrax vaccine,
Japanese encephalitis vaccines, hepatitis vaccines, human
papillomavirus vaccines, pneumococcal vaccines, meningococcal disease,
and an update on vaccines and other biologics for prevention and
treatment of healthcare-associated infections. A recommendation vote is
scheduled for hepatitis vaccines and evidence based recommendations.
Agenda items are subject to change as priorities dictate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2018-02268 Filed 2-5-18; 8:45 am]
BILLING CODE 4163-18-P
